WarfarinAnticoagulantsInternational Normalized RatioVitamin K Epoxide ReductasesGenotypeThromboembolismAtrial FibrillationHemorrhageProthrombin TimeAtrial Appendagebeta-AlaninePharmacogeneticsAryl Hydrocarbon HydroxylasesMixed Function OxygenasesDrug MonitoringVitamin KStrokeOral Surgical ProceduresVenous ThrombosisTreatment OutcomePulmonary EmbolismAspirinThrombosisDrug InteractionsBlood CoagulationEmbolismFactor VIIRisk FactorsVenous ThromboembolismRetrospective StudiesProspective StudiesDose-Response Relationship, DrugEchocardiography, TransesophagealPolymorphism, GeneticFollow-Up StudiesCohort StudiesBlood Loss, SurgicalAdministration, OralTime FactorsRecurrenceDrug Administration ScheduleRisk AssessmentAlgorithmsRodenticidesPolymorphism, Single NucleotidePractice Guidelines as TopicAllelesGene FrequencyPostoperative ComplicationsGenetic Predisposition to DiseaseGenetic VariationVitamin K 1